ID: ALA4786119

Max Phase: Preclinical

Molecular Formula: C23H21N3O3

Molecular Weight: 387.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCOC1(C(=C)c2nc(-c3ccccc3)no2)C(=O)N(CC)c2ccccc21

Standard InChI:  InChI=1S/C23H21N3O3/c1-4-15-28-23(18-13-9-10-14-19(18)26(5-2)22(23)27)16(3)21-24-20(25-29-21)17-11-7-6-8-12-17/h4,6-14H,1,3,5,15H2,2H3

Standard InChI Key:  XOXPRTJSXLBUHV-UHFFFAOYSA-N

Associated Targets(Human)

HFF-1 186 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma cruzi 99888 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leishmania infantum 5912 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.44Molecular Weight (Monoisotopic): 387.1583AlogP: 4.21#Rotatable Bonds: 7
Polar Surface Area: 68.46Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.57Np Likeness Score: -0.91

References

1. Fernandes FS,Santos H,Lima SR,Conti C,Rodrigues MT,Zeoly LA,Ferreira LLG,Krogh R,Andricopulo AD,Coelho F.  (2020)  Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids.,  201  [PMID:32590115] [10.1016/j.ejmech.2020.112418]

Source